Optimisation of microstructured biodegradable finasteride formulation for depot parenteral application

Journal of Microencapsulation
Osama A AhmedFatma M Mady

Abstract

This study aimed to use the biocompatibility features of the biodegradable polymers to prepare depot injectable finasteride (FIN) microspheres for the treatment of benign prostatic hyperplasia. FIN microspheres were prepared utilising an emulsion-solvent evaporation/extraction technique. The Box-Behnken experimental design was adopted to optimise the preparation process. FIN plasma levels in albino rabbits were determined after injection with optimised FIN microspheres formula and compared with oral FIN suspension. Results revealed that the optimum microspheres displayed an amended sustained release pattern with lower initial burst. The cumulative FIN % released after 25 days was in the range 27.83-73.18% for F4 and F1, respectively. The optimised formula, with 50.0% (X1), and 22.316% (X2) and 1.38% (X3) showed 6.503 μm, 93.213%, 14.574%, and 64.838% for Y1, Y2, Y3, and Y4, respectively. In vivo studies displayed a sustained release pattern with minimal initial burst release when injected into rabbits.

References

Jun 24, 1999·Journal of Biomedical Materials Research·L LuA G Mikos
May 5, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·C BerklandD W Pack
May 26, 2004·International Journal of Pharmaceutics·V R SinhaA Trehan
Oct 22, 2005·Journal of Clinical Pharmacology·Ryan Z TurncliffKenneth C Lasseter
Oct 31, 2006·Urology·Brent C TaylorUNKNOWN Osteoporotic Fractures in Men (MrOS) Study Research Group
May 9, 2007·International Journal of Pharmaceutics·Pushp R NepalHoo-Kyun Choi
Aug 8, 2007·International Journal of Pharmaceutics·Avinash BudhianKaren I Winey
Aug 28, 2007·Journal of Pharmaceutical Sciences·Stefano GiovagnoliCarlo Rossi
Dec 7, 2007·International Journal of Pharmaceutics·D KloseJ Siepmann
Jan 22, 2009·BJU International·J Kellogg ParsonsLynn M Marshall
Feb 4, 2009·Journal of Pharmaceutical Sciences·G Mittal, M N V Ravi Kumar
Jan 22, 2010·Journal of Biomedical Materials Research. Part a·Sarah A BurnsJoseph A Gardella
Apr 30, 2010·Expert Opinion on Pharmacotherapy·Deepani Rathnayake, Rodney Sinclair
Dec 8, 2010·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Dipti B Patel, Natubhai J Patel
Oct 24, 2012·AAPS PharmSciTech·Francesca SelminPatrick P DeLuca
Nov 23, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Thiago CaonValdir Soldi

❮ Previous
Next ❯

Citations

Apr 4, 2019·International Journal of Molecular Medicine·Ju Hee KimHyun-Shik Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.